Emerging drugs and targets for alzheimer's disease.

Other Authors: Martinez, Ana.
Format: Book
Language:English
Published: Cambridge, Royal Society of Chemistry, 2010.
Subjects:
Online Access:http://dx.doi.org/10.1039/9781849731065
LEADER 02043nam a2200229 a 4500
001 1873465
005 20171111234655.0
008 100122e201006uuxxka |s|||||||0|0 eng|d
020 |a 9781849731065:  |c £170.38 
020 |a 1849731063:  |c £170.38 
022 |a 2041-3203 
040 |a UK-WkNB  |b eng 
245 1 0 |a Emerging drugs and targets for alzheimer's disease.  |c Edited by Ana Martinez; Series edited by David E. Thurston. 
260 |a Cambridge,  |b Royal Society of Chemistry,  |c 2010. 
300 |a 287 p. :  |b 50 b&w, ill. 
500 |a Ebook. 
505 0 |a Beta-Amyloid as target-- Chapter 1: The amyloid hypothesis of AD and prospects for therapeutics-- Chapter 2: Targeting Alzheimer's ?-Secretase: Genetic and Chemical Modulation-- Chapter 3: Cholesterol and AD: the molecules, the targets-- Chapter 4: The Bimodal Features of Butyrylcholinesterase in Cholinergic Neurotransmission and Amyloid Suppression-- Chapter 5: Scyllo-inositol, a potential therapy for Alzheimer's disease-- Chapter 6: Immunotherapeutic strategies toward treatment of AD-- Tau protein as target-- Chapter 7: Alzheimer Neurofibrillary Degeneration: Pivotal Role and Therapeutic Targets-- Chapter 8: Multiple roles of glycogen synthase kinase-3 in AD-- Chapter 9: Tau protein kinases inhibitors: from the bench to the clinical trials-- Chapter 10: Activating PP2A as a therapeutic intervention strategy in AD-- Chapter 11: Rationale for tau aggregation inhibitor therapy in Alzheimer's disease and other tauopathies-- Glucose Metabolism as target-- Chapter 12: Insulin Insulin Resistance and neurodegeneration: Type 2 versus type 3 diabetes mellitus-- Chapter 13: Insulin-like Growth Factor I as a disease-modifying therapy in Alzheimer's disease-- Chapter 14: Ketone bodies as a therapeutic for Alzheimer's disease. 
650 7 |a Neurology & clinical neurophysiology. 
650 7 |a Pharmacology. 
700 1 |a Martinez, Ana. 
856 4 |a Thurston, David E.  |u http://dx.doi.org/10.1039/9781849731065 
952 |a CY-NiOUC  |b 5a0461cd6c5ad14ac1ee5ee0  |c 998a  |d 945l  |e -  |t 1  |x m  |z Books